Search Results

There are 10630 results for: content related to: The JR blood group system: identification of alleles that alter expression

  1. Molecular analysis of immunized Jr(a–) or Lan– patients and validation of a high-throughput genotyping assay to screen blood donors for Jr(a–) and Lan– phenotypes


    Volume 54, Issue 7, July 2014, Pages: 1836–1846, Lonneke Haer-Wigman, Aïcha Ait Soussan, Peter Ligthart, Masja de Haas and C. Ellen van der Schoot

    Version of Record online : 24 JAN 2014, DOI: 10.1111/trf.12544

  2. Defining the Jr(a–) phenotype in the Japanese population


    Volume 54, Issue 2, February 2014, Pages: 412–417, Mitsunobu Tanaka, Ikuko Kamada, Junko Takahashi, Keiko Kimura, Harumichi Matsukura and Yoshihiko Tani

    Version of Record online : 29 MAY 2013, DOI: 10.1111/trf.12277

  3. A new ABCG2 null allele with a 27-kb deletion including the promoter region causing the Jr(a−) phenotype


    Volume 55, Issue 6pt2, June 2015, Pages: 1467–1471, Kenichi Ogasawara, Takahiro Osabe, Yumi Suzuki, Hatsue Tsuneyama, Kazumi Isa, Miho Kawai, Kumi Obara, Yoshiko Ogiyama, Shoichi Ito, Makoto Uchikawa, Masahiro Satake and Kenji Tadokoro

    Version of Record online : 18 DEC 2014, DOI: 10.1111/trf.12969

  4. You have free access to this content
    Quantitative Analysis of the ABCG2 c.421C>A Polymorphism Effect on In Vivo Transport Activity of Breast Cancer Resistance Protein (BCRP) Using an Intestinal Absorption Model

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 9, September 2015, Pages: 3039–3048, Yuta Tanaka, Yoshiaki Kitamura, Kazuya Maeda and Yuichi Sugiyama

    Version of Record online : 30 JAN 2015, DOI: 10.1002/jps.24366

  5. Emily Cooley lecture 2012


    Volume 53, Issue 9, September 2013, Pages: 1876–1883, Marion E. Reid

    Version of Record online : 14 APR 2013, DOI: 10.1111/trf.12207

  6. The JR blood group system (ISBT 032): molecular characterization of three new null alleles


    Volume 53, Issue 7, July 2013, Pages: 1575–1579, Kim Hue-Roye, Christine Lomas-Francis, Gail Coghlan, Teresa Zelinski and Marion E. Reid

    Version of Record online : 15 OCT 2012, DOI: 10.1111/j.1537-2995.2012.03930.x

  7. ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin

    Clinical Pharmacology & Therapeutics

    Volume 86, Issue 2, August 2009, Pages: 197–203, JE Keskitalo, O Zolk, MF Fromm, KJ Kurkinen, PJ Neuvonen and M Niemi

    Version of Record online : 27 MAY 2009, DOI: 10.1038/clpt.2009.79

  8. Pharmacogenetic Characterization of Sulfasalazine Disposition Based on NAT2 and ABCG2 (BCRP) Gene Polymorphisms in Humans

    Clinical Pharmacology & Therapeutics

    Volume 84, Issue 1, July 2008, Pages: 95–103, Y Yamasaki, I Ieiri, H Kusuhara, T Sasaki, M Kimura, H Tabuchi, Y Ando, S Irie, JA Ware, Y Nakai, S Higuchi and Y Sugiyama

    Version of Record online : 2 JAN 2008, DOI: 10.1038/sj.clpt.6100459

  9. Expression levels of ABCG2 on cord red blood cells and study of fetal anemia associated with anti-Jra


    Volume 56, Issue 5, May 2016, Pages: 1171–1181, Satoko Fujita, Hirokazu Kashiwagi, Takuji Tomimatsu, Shoichi Ito, Kazuya Mimura, Takeshi Kanagawa, Masayuki Endo, Tomomitsu Miyoshi, Yasushi Okamura, Yoshihiko Tani, Yoshiaki Tomiyama and Tadashi Kimura

    Version of Record online : 11 FEB 2016, DOI: 10.1111/trf.13515

  10. You have free access to this content
    Ubiquitin-mediated proteasomal degradation of ABC transporters: a new aspect of genetic polymorphisms and clinical impacts

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 9, September 2011, Pages: 3602–3619, Hiroshi Nakagawa, Yu Toyoda, Kanako Wakabayashi-Nakao, Hideaki Tamaki, Masako Osumi and Toshihisa Ishikawa

    Version of Record online : 12 MAY 2011, DOI: 10.1002/jps.22615

  11. ABCG2 Polymorphism Is Associated With the Low-Density Lipoprotein Cholesterol Response to Rosuvastatin

    Clinical Pharmacology & Therapeutics

    Volume 87, Issue 5, May 2010, Pages: 558–562, B Tomlinson, M Hu, V W Y Lee, S S H Lui, T T W Chu, E W M Poon, G T C Ko, L Baum, L S Tam and E K Li

    Version of Record online : 3 FEB 2010, DOI: 10.1038/clpt.2009.232

  12. ABCG2 polymorphisms, 34G>A and 421C>A in a Korean population: analysis and a comprehensive comparison with other populations

    Journal of Clinical Pharmacy and Therapeutics

    Volume 35, Issue 6, December 2010, Pages: 705–712, K.-A. Kim, H.-J. Joo and J.-Y. Park

    Version of Record online : 3 NOV 2010, DOI: 10.1111/j.1365-2710.2009.01127.x

  13. Deletion of Exons 3 through 5 of ABCG2 causes the Jr(a−) phenotype in a West African woman


    Volume 55, Issue 11, November 2015, Pages: 2766–2767, Carole Saison, Jean-Pierre Cartron and Lionel Arnaud

    Version of Record online : 14 JUL 2015, DOI: 10.1111/trf.13223

  14. You have free access to this content
    Interaction of innovative small molecule drugs used for cancer therapy with drug transporters

    British Journal of Pharmacology

    Volume 165, Issue 2, January 2012, Pages: 345–362, K Mandery, H Glaeser and MF Fromm

    Version of Record online : 16 DEC 2011, DOI: 10.1111/j.1476-5381.2011.01618.x

  15. You have free access to this content
    The emerging pharmacotherapeutic significance of the breast cancer resistance protein (ABCG2)

    British Journal of Pharmacology

    Volume 151, Issue 2, May 2007, Pages: 163–174, L J A Hardwick, S Velamakanni and H W van Veen

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0707218

  16. The JR blood group system: genetic and molecular investigations

    ISBT Science Series

    Volume 7, Issue 1, July 2012, Pages: 260–263, G. Coghlan

    Version of Record online : 13 JUN 2012, DOI: 10.1111/j.1751-2824.2012.01558.x

  17. BCRP (ABCG2)

    Pharmacogenomics of Human Drug Transporters: Clinical Impacts

    Agnes Basseville, Susan E. Bates, William D. Figg, Alex Sparreboom, Pages: 311–343, 2013

    Published Online : 15 MAR 2013, DOI: 10.1002/9781118353240.ch14

  18. You have full text access to this OnlineOpen article
    Pilot PET Study to Assess the Functional Interplay Between ABCB1 and ABCG2 at the Human Blood–Brain Barrier

    Clinical Pharmacology & Therapeutics

    M Bauer, K Römermann, R Karch, B Wulkersdorfer, J Stanek, C Philippe, A Maier-Salamon, H Haslacher, C Jungbauer, W Wadsak, W Jäger, W Löscher, M Hacker, M Zeitlinger and O Langer

    Version of Record online : 9 MAY 2016, DOI: 10.1002/cpt.362

  19. ABCG2: A New Challenge in Cancer Drug Resistance

    ABC Transporters and Multidrug Resistance

    Orsolya Polgar, Robert W. Robey, Kin Wah To, John Deeken, Patricia A. Fetsch, Susan E. Bates, Pages: 83–117, 2009

    Published Online : 15 JUN 2009, DOI: 10.1002/9780470495131.ch3

  20. Association of enzyme and transporter genotypes with the pharmacokinetics of imatinib

    Clinical Pharmacology & Therapeutics

    Volume 80, Issue 2, August 2006, Pages: 192–201, Erin R. Gardner, Herman Burger, Ron H. van Schaik, Allan T. van Oosterom, Ernst A. de Bruijn, Gunther Guetens, Hans Prenen, Floris A. de Jong, Sharyn D. Baker, Susan E. Bates, William D. Figg, Jaap Verweij, Alex Sparreboom and Kees Nooter

    Version of Record online : 19 AUG 2006, DOI: 10.1016/j.clpt.2006.05.003